Publications by authors named "Jeff Jerman"

Claim this Profile
I
Investigating the potential of GalR2 as a drug target for neuropathic pain.
Kirsty Rich, Samrina Rehman, Jeff Jerman, Graeme Wilkinson

Neuropeptides· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel specific small-molecule melanocortin-2-receptor antagonist.
Rachel Forfar, Mashal Hussain, Puneet Khurana, Jennifer Cook, Steve Lewis, Jeff Jerman

Endocr Connect· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2.
Paul D Wright, David McCoull, Yvonne Walsh, Jonathan M Large, Barbara W Hadrys, Jeff Jerman

Biochem Biophys Res Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTH Antagonists.
Adrian John Clark, Rachel Forfar, Mashal Hussain, Jeff Jerman, Ed McIver

Front Endocrinol (Lausanne)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy.
Conor McCloskey, Cara Rada, Elizabeth Bailey, Samantha McCavera, Hugo A van den Berg, Jeff Jerman

EMBO Mol Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining the potential of label-free biosensors for seven-transmembrane receptor drug discovery.
Magalie Rocheville, Julio Martin, Jeff Jerman, Evi Kostenis

Prog Mol Biol Transl Sci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK.
Paul D Wright, Gregory Weir, Jamie Cartland, David Tickle, Catherine Kettleborough, Jeff Jerman

Biochem Biophys Res Commun· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput identification and characterization of novel, species-selective GPR35 agonists.
Zaynab Neetoo-Isseljee, Amanda E MacKenzie, Craig Southern, Jeff Jerman, Edward G McIver

J Pharmacol Exp Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
7
7TM pharmacology measured by label-free: a holistic approach to cell signalling.
Magalie Rocheville, Jeff C Jerman

Curr Opin Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus.
Ellen M Soffin, Catherine H Gill, Stephen J Brough, Jeff C Jerman, Ceri H Davies

Neuropharmacology· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives.
Hiroyuki Watanabe, John B Davis, Darren Smart, Jeff C Jerman, Graham D Smith

J Biol Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis